# Clopidogrel Resistance and Embolism in Carotid Artery Stenting

> **NCT02133989** · PHASE3 · UNKNOWN · sponsor: **Samsung Medical Center** · enrollment: 86 (estimated)

## Conditions studied

- Carotid Stenosis

## Interventions

- **DRUG:** Ticlopidine + Ginko biloba
- **DRUG:** Clopidogrel

## Key facts

- **NCT ID:** NCT02133989
- **Lead sponsor:** Samsung Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-06
- **Primary completion:** 2017-12
- **Final completion:** 2017-12
- **Target enrollment:** 86 (ESTIMATED)
- **Last updated:** 2017-04-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02133989

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02133989, "Clopidogrel Resistance and Embolism in Carotid Artery Stenting". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02133989. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*